Track Enochian Biosciences, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Enochian Biosciences, Inc. ENOB · Stock Open Enochian Biosciences, Inc. in new tab

0.7125 USD
Loading chart...

DCF valuation

Model fair value for Enochian Biosciences, Inc. (ENOB)
Result
Sign in to run the valuation for ENOB.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Enochian Biosciences, Inc. Logo Enochian Biosciences, Inc. Analysis (ENOB)

United States Health Care Official Website Stock

Is Enochian Biosciences, Inc. a good investment? Enochian Biosciences, Inc. (ENOB) is currently trading at 0.7125 USD.

Investor FAQ

Does Enochian Biosciences, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Enochian Biosciences, Inc.?

Enochian Biosciences, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

Company Profile

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-DC-11 off the shelf DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intraturmoral injection. Enochian Biosciences, Inc. has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Research Center, the Texas Biomedical Research Institute, the University of California, Los Angeles, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. The company was incorporated in 2017 and is headquartered in Los Angeles, California.

Exchange Ticker
NMS (United States) ENOB
NMS (United States) RENB
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion